Synova Capital

What is Synova Capital?

Synova Capital is a private equity firm with headquarters in New York, United States, and an additional office in London, United Kingdom. The firm was founded in 2007 and specializes in equity investments.

Synova invests through various stages including series A, series B, late-stage, early-stage, and seed rounds, primarily focusing on the biotech, medical devices, hospital services, business services, consumer brands, software, information technology, healthcare, education, and financial services sectors.

They have a strong expertise in partnering with companies where they can leverage their deep investment and operational knowledge to help their partners excel and achieve growth. Synova Capital is committed to building real and personal partnerships with founders and managers, maintaining that their approach to working closely with their partners is a key contributor to their success.

Their investment model prioritizes enhancing capabilities within their portfolio companies to meet ambitious targets.

Furthermore, Synova emphasizes international expansion by leveraging their network to help companies access new markets, and they are keen on harnessing the power of technology and data to drive transformations.

Synova has a proven record of successful investments and exits, highlighted by awards and press releases that celebrate their accomplishments such as top private equity firm rankings and substantial returns on investments such as 4.5x on the sale of Avantra and 7.3x on InsurEvo. Synova LLP is regulated in the UK by the Financial Conduct Authority, showcasing their commitment to professional and legal standards in their activities.